Related references
Note: Only part of the references are listed.In vitro inhibition of Mycobacterium tuberculosis ?-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos
Ashok Aspatwar et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695
Mohammad M. Rahman et al.
GUT PATHOGENS (2020)
Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus
Jatinder Kaur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Anion Inhibition Studies of the Beta-Carbonic Anhydrase from Escherichia coli
Sonia Del Prete et al.
MOLECULES (2020)
Escherichia coli gamma-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae
Silvia Bua et al.
BIOORGANIC CHEMISTRY (2019)
A new widespread subclass of carbonic anhydrase in marine phytoplankton
Erik L. Jensen et al.
ISME JOURNAL (2019)
Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
Ashok Aspatwar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pseudomonas aeruginosa β-carbonic anhydrase, psCA1, is required for calcium deposition and contributes to virulence
Shalaka R. Lotlikar et al.
CELL CALCIUM (2019)
Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori
Maurizio Ronci et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Anti-Helicobacter pylori activity of ethoxzolamide
Joyanta K. Modak et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Selenides bearing benzenesulfonamide show potent inhibition activity against carbonic anhydrases from pathogenic bacteria Vibrio cholerae and Burkholderia pseudomallei
Andrea Angeli et al.
BIOORGANIC CHEMISTRY (2018)
Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273
Tanvi V. Wani et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae - and -class enzymes
Silvia Bua et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
Takefumi Komiya et al.
FRONTIERS IN ONCOLOGY (2018)
Structure-Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity
Avni Bhatt et al.
CHEMBIOCHEM (2017)
Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties
Daniela De Vita et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
A one-step procedure for immobilising the thermostable carbonic anhydrase (SspCA) on the surface membrane of Escherichia coli
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Inhibition studies of Brucella suis β-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides
Simona Maria Monti et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis
Rosa Perfetto et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Brucella suis carbonic anhydrases and their inhibitors: Towards alternative antibiotics?
Stephan Kohler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Comparison of the Sulfonamide Inhibition Profiles of the - and -Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei
Daniela Vullo et al.
MOLECULES (2017)
Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
An Overview of the Bacterial Carbonic Anhydrases
Claudiu T. Supuran et al.
METABOLITES (2017)
Acyl selenoureido benzensulfonamides show potent inhibitory activity against carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Andrea Angeli et al.
BIOORGANIC CHEMISTRY (2017)
Anion inhibitors of the β-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Kinetic properties and affinities for sulfonamide inhibitors of an α-carbonic anhydrase (CruCA4) involved in coral biomineralization in the Mediterranean red coral Corallium rubrum
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Comparison of the anion inhibition profiles of the β- and γ-carbonic anhydrases from the pathogenic bacterium Burkholderia pseudomallei
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization
Ozen Ozensoy Guler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puscas (1932-2015)
Gyorgy M. Buzas et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111
Carrie L. Lomelino et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines
Nagwa M. Abdel Gawad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Anion inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches
Giannamaria Annunziato et al.
CHEMMEDCHEM (2016)
New drugs for bad bugs: what’s new and what’s in the pipeline?
V. Erdeljic Turk et al.
CLINICAL THERAPEUTICS (2016)
An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis
Clemente Capasso et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Pathogenesis of Helicobacter pylori infection
Steffen Backert et al.
HELICOBACTER (2016)
Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan
Lauren C. Kinkead et al.
IMMUNOLOGICAL REVIEWS (2016)
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents
Jorge R. A. Diaz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Carbonic anhydrase inhibition and the management of neuropathic pain
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets
Claudiu T. Supuran
PATHOGENS (2016)
Non-Classical Inhibition of Carbonic Anhydrase
Carrie L. Lomelino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Cloning, characterization and anion inhibition study of a β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans
Nurcan Dedeoglu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa
Melissa A. Pinard et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The zinc coordination pattern in the η-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families
Giuseppina De Simone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense
Giuseppina De Simone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans
Nurcan Dedeoglu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Bad Bugs, No Drugs: Are We Part of the Problem, or Leaders in Developing Solutions?
Brooke Decker et al.
CRITICAL CARE MEDICINE (2015)
An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors
C. Capasso et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
N-glycosyl-N-hydroxysulfamides as potent inhibitors of Brucella suis carbonic anhydrases
Joanna Ombouma et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Maturation of Oral Microbiota in Children with or without Dental Caries
Pernilla Lif Holgerson et al.
PLOS ONE (2015)
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Marta Ferraroni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2015)
Acidogenicity and acidurance of dental plaque and saliva sediment from adults in relation to caries activity and chlorhexidine exposure
Andreadis Georgios et al.
JOURNAL OF ORAL MICROBIOLOGY (2015)
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
The oral microbiome diversity and its relation to human diseases
Jinzhi He et al.
FOLIA MICROBIOLOGICA (2015)
Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis
Ahmed M. Alafeefy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides
Joyanta K. Modakh et al.
PLOS ONE (2015)
Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: The β-class (PgiCAb) versus the γ-class (PgiCA) enzymes
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae
Ahmed M. Alafeefy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Anion inhibition study of the β-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis γ-carbonic anhydrase
Mariangela Ceruso et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors
Laura De Luca et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N′-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII
Beata Zolnowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Sulfonamides and their isosters as carbonic anhydrase inhibitors
Fabrizio Carta et al.
FUTURE MEDICINAL CHEMISTRY (2014)
3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules
Shalini Singh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Biochemical characterization of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Biochemical properties of a new α-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae
Sonia Del Prete et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis
Mariangela Ceruso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Sulfonamides with Potent Inhibitory Action and Selectivity against the α-Carbonic Anhydrase from Vibrio cholerae
Mariangela Ceruso et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
X-ray structure of the first 'extremo-α-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1
Anna Di Fiore et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
Anion inhibition studies of a β-carbonic anhydrase from Clostridium perfringens
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Anion inhibition studies of the α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
A highly catalytically active γ-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules
Sonia Del Prete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis
Alfonso Maresca et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids
Alfonso Maresca et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
The oral microbiome in health and disease
William G. Wade
PHARMACOLOGICAL RESEARCH (2013)
Mechanisms of Francisella tularensis Intracellular Pathogenesis
Jean Celli et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii
Vincenzo Alterio et al.
BIOCHIMIE (2012)
Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata
Simona Maria Monti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations
Fabrizio Carta et al.
CHEMICAL COMMUNICATIONS (2012)
Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology
S. Khelaifia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
(In)organic anions as carbonic anhydrase inhibitors
Giuseppina De Simone et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
DNA Cloning, Characterization, and Inhibition Studies of an α-Carbonic Anhydrase from the Pathogenic Bacterium Vibrio cholerae
Sonia Del Prete et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo
Fabrizio Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth
Pascale Joseph et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Claudiu T. Supuran
FRONTIERS IN PHARMACOLOGY (2011)
Bishydrazide Glycoconjugates for Lectin Recognition and Capture of Bacterial Pathogens
Avijit Kumar Adak et al.
BIOCONJUGATE CHEMISTRY (2010)
Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate
Alessio Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The beta-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Cloning, Characterization, and Inhibition Studies of a β-Carbonic Anhydrase from Brucella suis
Pascale Joseph et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Helicobacter pylori– 2010
György Miklós Buzás
ORVOSI HETILAP (2010)
Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 β-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides
Alfonso Maresca et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Bicarbonate Induces Vibrio cholerae Virulence Gene Expression by Enhancing ToxT Activity
Basel H. Abuaita et al.
INFECTION AND IMMUNITY (2009)
Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosis
Isao Nishimori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Molecular Cloning, Characterization, and Inhibition Studies of the Rv1284 β-Carbonic Anhydrase from Mycobacterium tuberculosis with Sulfonamides and a Sulfamate
Tomoko Minakuchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: Drug design and mechanism of action
Anne Thiry et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The alpha and beta classes carbonic Anhydrases from Helicobacter pylori as novel drug targets
Isao Nishimori et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Carbonic anhydrases - An overview
Claudiu T. Supuran
CURRENT PHARMACEUTICAL DESIGN (2008)
Evolution of structure in γ-class carbonic anhydrase and structurally related proteins
Xiang Fu et al.
MOLECULAR PHYLOGENETICS AND EVOLUTION (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Carbonic anhydrase inhibitors:: The β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Carbonic anhydrase inhibitors as anticonvulsant agents
Anne Thiry et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Carbonic Anhydrases as drug targets - An overview
Claudiu T. Supuran
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Carbonic anhydrase inhibitors:: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori
I Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Salmonella enterica highly expressed genes are disease specific
C Rollenhagen et al.
INFECTION AND IMMUNITY (2006)
Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo:: A pilot study
R Shahidzadeh et al.
HELICOBACTER (2005)
Why is carbonic anhydrase essential to Escherichia coli?
C Merlin et al.
JOURNAL OF BACTERIOLOGY (2003)
Macrolide antibiotics: Binding site, mechanism of action, resistance
M Gaynor et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Carbonic anhydrase is essential for growth of Ralstonia eutropha at ambient CO2 concentrations
B Kusian et al.
JOURNAL OF BACTERIOLOGY (2002)
Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties
B Masereel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Crystal structure of E-coli β-carbonic anhydrase, an enzyme with an unusual pH-dependent activity
JD Cronk et al.
PROTEIN SCIENCE (2001)
Arylsulfonyl-N,N-dialkyl-dithiocarbamates as tumor cell growth inhibitors: Novel agents targeting beta-tubulin?
A Scozzafava et al.
JOURNAL OF ENZYME INHIBITION (2001)
Arylsulfonyl-N,N-diethyl-dithiocarbamates:: A novel class of antitumor agents
A Scozzafava et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
